Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11667613 Antiviral pyrazolopyridinone compounds
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 7 Jun, 2023
"Created via: Entity Importer"
Golden AI
created this topic on 7 Jun, 2023
Edits made to:
Infobox
(
+18
properties)
US Patent 11667613 Antiviral pyrazolopyridinone compounds
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11667613
0
Date of Patent
June 6, 2023
0
Patent Application Number
17030540
0
Date Filed
September 24, 2020
0
Patent Citations
US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
0
US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
0
US Patent 8388967 Methods for inducing or enhancing an immune response by administering agonistic GITR-binding antibodies
0
US Patent 8586023 Cell capable of expressing exogenous GITR ligand
0
US Patent 8591886 Combination therapies employing GITR binding molecules
0
US Patent 8609089 Compositions of PD-1 antagonists and methods of use
0
Patent Primary Examiner
Brenda L Coleman
0
CPC Code
C07D 471/14
0
C07D 471/04
0
A61P 31/22
0
A61K 31/437
0
A61K 31/4162
0
Find more entities like US Patent 11667613 Antiviral pyrazolopyridinone compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE